What's New

Biospecimen Tables

07/06/2021 – Primary Diagnosis and Second Malignancy

Recent CCSS Publications

  • Gupta AC, Owens CA, Shrestha S, Lee C, Smith SA, Weathers RE, Netherton T, Balter PA, Kry SF, Followill DS, Griffin KT, Long JP, Armstrong GT, Howell RM. Body region-specific 3D age-scaling functions for scaling whole-body computed tomography anatomy for pediatric late effects studies. Biomed Phys Eng Express, 2022; 8(2)5051
  • Man T, Aubert G, Richard MA, LeJeune W, Hariri E, Goltsova T, Gaikwad A, Chen Y, Whitton J, Leisenring WM, Arnold MA, Neglia JP, Yasui Y, Robison LL, Armstrong GT, Bhatia S, Gramatges MM. Short NK- and Naïve T-Cell telomere length is associated with thyroid cancer in childhood cancer survivors: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev, 2022; 31(2):453-460
  • Dixon SB, Chen Y, Yasui Y, Pui C, Hunger SP, Silverman LB, Ness KK, Green DM, Howell RM, Leisenring WM, Kadan-Lottick NS, Krull KR, Oeffinger KC, Neglia JP, Hudson MM, Robison LL, Mertens LL, Armstrong GT, Nathan PC. Impact of risk-stratified therapy on health status in survivors of childhood Acute Lymphoblastic Leukemia: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev, 2022; 31(1):150-160
  • Yeh JM, Lowry KP, Schechter CB, Diller LR, O’Brien G, Alagoz O, Armstrong GT, Hampton JM, Hudson MM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Nathan PC, Neglia JP, Oeffinger KC, Trentham-Dietz A, Stout NK. Breast cancer screening among childhood cancer survivors treated without chest radiation: clinical benefits and cost-effectiveness.  J Natl Cancer Inst, 2022; 114(2):235-244

Latest results from long-term follow-up study